Liberty Cantrell
MSc, BSc
Medical Statistician & DPhil Student
Liberty joined the Oxford Vaccine Group in 2021 after graduating from the University of Nottingham with a BSc in Mathematics and an MSc in Statistics. Since joining the team she has worked across a variety of research areas including COVID-19, pertussis and group B streptococcus (GBS).
Liberty started her DPhil in 2023 studying correlates of protection for vaccines against GBS. During this work, she is investigating antibody levels associated with a reduced risk of infant disease using case-control data from countries across Europe and Africa. She has also been conducting simulation studies to investigate the impact of the choice of analysis method on the results.
Her research interests include vaccinations during pregnancy and correlates of protection.
Recent publications
-
Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.
Journal article
Mugo AG. et al, (2025), BMC Infect Dis, 25
-
Influence of context on engagement with COVID-19 testing: a scoping review of barriers and facilitators to testing for healthcare workers, care homes and schools in the UK.
Journal article
Andersen-Waine B. et al, (2025), BMJ Open, 15
-
Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14,805 care homes in England
Journal article
Lambert BEN. et al, (2025), BMJ Public Health
-
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.
Journal article
Nakabembe E. et al, (2025), Lancet Glob Health, 13, e81 - e97
-
Understanding COVID-19 testing behaviour in England through a sociodemographic lens : a population based study
Journal article
Bajaj S. et al, (2024), The Lancet Digital Health